Clinical trial NCT03637920: Sexuality in Transmen During Hormone and Operative Treatment
Official title: Sexuality in Transmen During Hormone and Operative Treatment Compared to Cisgender Women and Men: a Follow-up Study
Study type: OBSERVATIONAL
Overall status: UNKNOWN
Conditions: Gender Dysphoria
Gender Identity Disorder
Transsexualism
Body Image
Sexuality
Keywords: Transmen
Sexuality
Sexual behavior
Body Image
Trassexualism
Lead sponsor: Medical University of Graz
Sponsor class: OTHER
First posted: 2018-08-20
Enrollment: 160
Sex: ALL
Minimum age (years): 18
Maximum age (years): 50
Standard ages: ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The study includes biological women, who identify as men and are planning to go through gender reassignment. The participants age is between 18 and 50.

Participants are recruited at the Medical University Hospital of Graz and the consulting center "Courage".

Brief summary: With this analysis the investigators aim at discovering a difference in sexuality between transmen, cissexual women and cissexual men. A potential impact of body satisfaction will also be explored. Furthermore the investigators want to assess the gender dysphoria in transmen.

Detailed description: The aim of the study is to investigate transmen's sexuality and body satisfaction during hormonal and surgical reassignment. Furthermore sexual orientation, sexual behavior and gender dysphoria will be assessed.

Therefore an online survey with five measurements throughout the gender reassignment treatment is conducted. As a matter of Routine, postoperative complications will be recorded retrospectively. To compare transmen's data with cisgender women and men we will be using data of the questionnaire's validation studies.

The following questionnaires are used:

Sexuality: Multidimensionaler Fragebogen zur Sexualität (Brenk-Franz \& Strauß, 2011).

Sexual orientation: Fragebogen zur Sexualgeschichte und zum sexuellen Verhalten (Brenk, 2005) Gender dysphoria: Utrecht Gender Dysphoria Scale (Cohen-Kettenis \& Van Goozen, 1997) Body image: Fragebogen zum Körperbild (Clement \& Löwe, 1996) Sociodemographic questionnaire: age, education, work, living situation, relationship status, gender reassignment treatment so far, coming out Case report form

T0: baseline measurement (patient is at the start of the hormonal treatment or has already startet but has not undergone any gender reassignment surgery) T1: within 2 weeks before the mastectomy T2: 6 months (+/- 2 weeks) after mastectomy T3: 6 months (+/- 2 weeks) after colpectomy T4: 6 months (+/- 2 weeks) after the last gender reassignment surgery

Eligibility criteria: Inclusion Criteria:

* Transsexualism (Female to Male) approved by a psychologist's oder psychiatrist's report
* good German skills
* fully competent
* good computer skills

Exclusion Criteria:

* insufficient German
* patient rejects the participation

Primary outcomes:
measure: Changes in sexuality due to hormonal treatment using the Multidimensional Sexuality Questionnaire
timeFrame: 2 years
Secondary outcomes:
measure: Changes in sexuality due to surgical reassignment using the Multidimensional Sexuality Questionnaire
timeFrame: 5 years
measure: Changes in sexual history due to surgical reassignment using the Fragebogen zur Sexualgeschichte und zum sexuellen Verhalten
timeFrame: 5 years
measure: Changes in body image during sexual reassignment therapy using the Fragebogen zum Körperbild
timeFrame: 5 years
measure: Gender dysphoria using the Utrecht Gender Dysphoria Scale
timeFrame: 5 years
measure: Sexuality in transmen compared to cisgender women and men using the Multidimensional Sexuality Questionnaire
timeFrame: 5 years
measure: Sexual history in transmen compared to cisgender women and men using the Fragebogen zur Sexualgeschichte und zum sexuellen Verhalten
timeFrame: 5 years
measure: Changes in sexual history due to hormonal treatment using the Fragebogen zur Sexualgeschichte und zum sexuellen Verhalten
timeFrame: 2 years
Other outcomes:
Locations:
city: Graz
country: Austria
facility: Medical University Graz
state: Styria
Study officials:
affiliation: Medical University of Graz
name: Daniela Ulrich, Assoc Prof, MD PhD
role: PRINCIPAL_INVESTIGATOR
References: